AngioDynamics traded at $19.80 this Wednesday July 6th, increasing $0.11 or 0.56 percent since the previous trading session. Looking back, over the last four weeks, AngioDynamics gained 4.49 percent. Over the last 12 months, its price fell by 27.31 percent. Looking ahead, we forecast AngioDynamics to be priced at 19.01 by the end of this quarter and at 17.51 in one year, according to Trading Economics global macro models projections and analysts expectations.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
Terumo 4,099.00 -1.00 -0.02% -8.34%
AngioDynamics 19.80 0.11 0.56% -27.31%
Accuray 2.01 -0.06 -2.90% -55.43%
AtriCure 42.61 0.11 0.26% -47.67%
Natus Medical 32.68 -0.14 -0.43% 29.12%
Boston Scientific 37.66 -0.10 -0.26% -14.27%
Artivion Inc 19.33 -0.06 -0.31% -31.14%
Cardiovascular Systems 14.82 -0.03 -0.20% -65.43%
Edwards Lifesciences 97.98 0.01 0.01% -9.18%
ICU Medical 164.81 -1.50 -0.90% -21.26%
Inogen 26.81 1.72 6.86% -60.13%
J&J 178.30 0.16 0.09% 5.25%
Medtronic 89.62 -0.87 -0.96% -29.84%
Mesa Laboratories 201.66 -2.93 -1.43% -26.83%
Merit Medical Systems 53.36 -1.10 -2.02% -16.03%
Orthofix International 24.14 -0.26 -1.07% -38.18%
Smiths 1,384.00 20.00 1.47% -13.85%
Surmodics 37.60 -0.87 -2.26% -29.60%
Teleflex 251.80 -0.45 -0.18% -40.27%
Tandem Diabetes Care 62.97 -0.26 -0.41% -36.82%
Trinity Biotech 1.30 -0.08 -5.80% -49.22%

Indexes Price Day Year
USND 11362 39.61 0.35% -22.52%
US2000 1728 -13.78 -0.79% -23.32%

AngioDynamics
AngioDynamics, Inc. designs, manufactures and sells a range of medical, surgical and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease, vascular access and for use in oncology and surgical settings. Its devices are used in minimally invasive, image-guided procedures. Its product offerings include Endovascular Therapies, Oncology/Surgery (OS) and Vascular Access (VA). Its Endovascular Therapies product offerings support the medical areas of Thrombus Management, Atherectomy, Peripheral Products (Core) and Venous Insufficiency. Its OS product offerings includes a range of ablation technologies, including thermal tissue ablation systems, surgical resection and the Irreversible Electroporation (IRE) technology, the NanoKnife System. Its portfolio of VA products includes peripherally inserted central catheters (PICCs), midline catheters, implantable ports, dialysis catheters and related accessories and supplies.